Table 3.
Disease-free survival in RWE studies.
| First Author (year) | Follow-up | Event-free (%) |
|---|---|---|
| Kwak (2015) | 5 years | ET arm: 76.2 |
| Alramadhan (2016) | 5 years | ET arm: 98.9 |
| Shimazu (2019) | 6 years | osN0: 92.4 pN0: 87.0 |
Abbreviations: ET = endocrine therapy; osN0 = negative sentinel lymph nodes assessed by one-step nucleic acid amplification; pN0 = negative sentinel lymph node assessed by pathology; RWE = real-world evidence.